Navigation Links
Oramed Pharmaceuticals Launches GLP1-Analog Program, Based on its Proprietary Drug Delivery Platform
Date:9/16/2008

ORMD 0901 is Being Developed as an Oral Dosage Form of a GLP1-analog Aimed

at Improving Glycemic Control in Adults With Type 2 Diabetes

JERUSALEM, Israel, September 16 /PRNewswire-FirstCall/ -- Oramed Pharmaceuticals, Inc. (OTCBB: ORMP.OB), a developer of oral drug delivery systems, announced today that it has launched pre-clinical trials of ORMD 0901, a GLP1-analog.

ORMD 0901 belongs to the Incretin family of drugs which helps to manage diabetes, including reduction in blood glucose levels and inhibiting glucagon secretion.

Incretins have been cited in causing regeneration of pancreatic insulin secreting cells, and in tissue protective properties including protection of the heart. GLP1 and analogs are associated with gradual weight loss, which is very desirable in diabetes patients.

"The launch of pre-clinical trials of ORMD 0901 and expansion of Oramed's platform marks the next strategic milestone for our company as we demonstrate the effectiveness of our oral delivery technology in yet another important family of polypeptide drugs for diabetes, that are until now only available in injection form," said Oramed CEO Nadav Kidron.

We plan to conduct the ORMD 0901 trials at Hadassah University Medical Center and they are expected to conclude by the end of 2008.

Oramed plans to launch phase 2b trials of ORMD 0801, its oral insulin capsule, in India in the first quarter of 2009.

About Oramed Pharmaceuticals

Oramed Pharmaceuticals is a technology pioneer in the field of oral delivery solutions for drugs presently delivered via injection. Oramed is seeking to revolutionize the treatment of diabetes through its patented flagship product, an orally ingestible insulin capsule currently in phase 2 clinical trials. Established in 2006, Oramed's technology is based on over 25 years of research by top research scientists at Jerusalem's Hadassah Medical Center. The Company's corporate and R&D headquarters are b
'/>"/>

SOURCE Oramed Pharmaceuticals Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. Oramed Pharmaceuticals to Hold Conference Call on August 6 to Present Results of Phase 2A Oral Insulin Capsule Clinical Trials
2. Oramed Pharmaceuticals Announces Successful Phase 2A Clinical Trial of its Oral Insulin Capsule
3. Oramed Pharmaceuticals Chosen to Present Oral Insulin Trial Results at EASD Conference (September 7-11, Rome)
4. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
5. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
6. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
7. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
8. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
9. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
10. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
11. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)..., , LAS ANGELES, December 2 /PRNew...TCBB: FHAI) announced today that it would initiate...eeping them informed of the significant,progress w...usiness plan, as,well as to provide shareholders w... against Dunn Capital Partners and others. , ...
(Date:12/2/2009)..., , CENTENNIAL, Colo., Dec. 2 /PRNewswire...rofit providers of skin, bone and soft tissue allo...d,s largest processor of live cellular bone growth... truly iconic symbol of hope as a float rider aboa...2010 Tournament of Roses Parade®. Manuel Sal...
(Date:12/2/2009)..., , DUBLIN, Ohio, Dec. 2 /PRNewswire-First...ie Cox will serve on the company,s board of direct...cently served as executive vice president and pres... Corp. She completed her tenure with the company a...,, Prior to her term at Schering-Plough, Cox se...
Breaking Medicine Technology:Fountain Healthy Aging Inc Business Update For Shareholders 2Fountain Healthy Aging Inc Business Update For Shareholders 3AlloSource Sponsors Heroic Quadruple Amputee as Rider Aboard 2010 Donate Life Rose Parade Float 2AlloSource Sponsors Heroic Quadruple Amputee as Rider Aboard 2010 Donate Life Rose Parade Float 3Cardinal Health Names Carrie Cox to Board of Directors 2Obama Speech Heralds Prevention Power of Screening Tests Like Colonoscopy 56843 1Obama Speech Heralds Prevention Power of Screening Tests Like Colonoscopy 56843 2Obama Speech Heralds Prevention Power of Screening Tests Like Colonoscopy 56843 3H1N1 Swine Flu Preparedness Uncertainty Results in Higher Business Disruption Risk 56840 1H1N1 Swine Flu Preparedness Uncertainty Results in Higher Business Disruption Risk 56840 2Most Pharmaceutical Companies Receive Poor Grades on HIV AIDS Drug Development Innovation According to AIDS Treatment Activist Coalition Report Card 56837 1Most Pharmaceutical Companies Receive Poor Grades on HIV AIDS Drug Development Innovation According to AIDS Treatment Activist Coalition Report Card 56837 2Most Pharmaceutical Companies Receive Poor Grades on HIV AIDS Drug Development Innovation According to AIDS Treatment Activist Coalition Report Card 56837 3
(Date:12/2/2009)...est improvement seen for advanced cases, study fin...) -- In the past two decades, survival rates for a...have improved modestly, a new study has found. ,...atients diagnosed with stage 4 non-small cell lung... information was in the U.S. National Cancer Insti...
(Date:12/2/2009)...dy finds rising incidence of obesity could counter...SDAY, Dec. 2 (HealthDay News) -- The overall healt...t three decades, largely because people have quit ...gains might soon be wiped out if the rising obesit..., If current trends in both smoking and obesity ...
(Date:12/2/2009)...emen especially likely to have metabolic syndrome,...thDay News) -- Exercise alone isn,t enough to keep... higher risk for a medical condition that can lead...archers studied linemen at Division I colleges and...rcent had metabolic syndrome, a group of condition...
(Date:12/2/2009)...added batches now available, many more to come, NI...(HealthDay News) -- Thirteen stem cell lines have...r taxpayer-funded research, and many more such lin...als announced Wednesday. , These are the first ...research funded by the U.S. National Institutes of...
(Date:12/2/2009)... , VIRGINIA BEACH, Va., Dec. 2 /PRNewswire/...tte. These smokeless cigarettes continue to grow i...t is now available at the PremiumEcigarette - the ...nic cigarette - at the amazingly low price of $14....people to try the e-cigarette at a very low price,...
Breaking Medicine News(10 mins):Health News:Gains Made in Lung Cancer Survival 2Health News:Health Gains From Lowered Smoking Rates in Jeopardy 2Health News:Health Gains From Lowered Smoking Rates in Jeopardy 3Health News:Oversized College Football Players May Face Heart Risks 2Health News:U.S. Approves New Stem Cell Lines for Publicly Funded Research 2Health News:U.S. Approves New Stem Cell Lines for Publicly Funded Research 3Health News:A Smokeless Holiday Season? Premium Electronic Cigarette Announces New Disposable Smokeless Cigarette Product 2
... Nov. 26 /PRNewswire-FirstCall/ - Cardiome Pharma ...dated guidance for expected,interim results from i...,Cardiome had originally intended to complete and ... the final study,results to be presented in mid-20...
...receive treatment that is contraindicated by pre-e...ion, according to a new study. Dr. James Talcott o... co-investigators found that patients with certain...ary 1, 2008 issue of CANCER, a peer-reviewed journ...
...ior Writer Suzanne Smalley looks at,GOP presidenti...nces that,explain his moral code, which is at once... The roots of Giuliani,s outsized, complex adult p...h a,strict moral code but always holding out the p...
...onary New Artis zeego*, Which Employs Robotic T...oning Capabilities, ...://www.usa.siemens.com/medical ) introduces its ne...clinical,environments, from body and neurointerven...
...start in the womb, experts say , , SUNDAY,...Americans is improving as people take better care ... extend to some of the country,s most vulnerable i...r-olds increased from 24 percent to 28 percent fro...
...day,shopping season is underway and many Americans...roducts they buy -- many of which are imported. Wi...ry Mike Leavitt will visit,Pike Place Market on We...veloped by an intra-governmental Import Safety Wor...
Other Medicine News:Health News:Cardiome Updates Guidance 2Health News:Cardiome Updates Guidance 3Health News:Cardiome Updates Guidance 4Health News:Many prostate cancer patients receive improper or 'mismatched' therapies 2Health News:NEWSWEEK: Media Lead Sheet/December 3, 2007 Issue (on newsstands Monday, November 26). 2Health News:NEWSWEEK: Media Lead Sheet/December 3, 2007 Issue (on newsstands Monday, November 26). 3Health News:NEWSWEEK: Media Lead Sheet/December 3, 2007 Issue (on newsstands Monday, November 26). 4Health News:Siemens Introduces Its New Generation of Artis Interventional Imaging Systems 2Health News:Siemens Introduces Its New Generation of Artis Interventional Imaging Systems 3Health News:Siemens Introduces Its New Generation of Artis Interventional Imaging Systems 4Health News:Siemens Introduces Its New Generation of Artis Interventional Imaging Systems 5Health News:Tooth Decay Is Kids' Stuff 2Health News:Tooth Decay Is Kids' Stuff 3Health News:HHS Secretary to Visit Pike Place Market to Discuss Import Safety, Preview Trip to China 2
Syringe Avitene
... based upon the physiological form and function of...s and morphology of the implant design integrates ...ysiological spine. Modular design concept: Three i...ls: Forged cobalt-chrome alloy endplate elements, ...
Mach4 Surgical Navigation Software
Kambin Radiolucent Spinal Frame
Medicine Products: